Investigators used in vivo confocal microscopy (IVCM) to evaluate microstructural changes in the meibomian glands in patients with active and inactive TED.
Technologies are giving ophthalmologists objective, and in some cases interchangeable, tools for evaluating dry eye.
The study suggests that inflammation and serotonin dysfunction are responsible for the correlation.
Monica Dweck, MD, of New York Eye and Ear Infirmary of Mount Sinai, Nandini Venkateswaran, MD, of Massachusetts Eye and Ear, and Laura Di Meglio, OD, of the Wilmer Eye Institute, among other clinicians, offer guidance on advising patients on the ocular dangers of cosmetics abuse.
Research shows treatment with an eyelid warming device can help reduce dry signs and symptoms.
A study shows how masks designed to alleviate ocular stress can also help manage mental health.
The study found that alcohol may have a protective effect against dry eye disease in men.
Research shows the treatment provides swift recovery of inflammation from corneal fibres.
Researchers summarize the potential pathophysiological mechanisms and histopathological features of lid margin keratinization.
Dry eye disease study with 78,000 participants demonstrates “substantial reduction” to both physical and mental wellbeing.
The Tear Film & Ocular Surface Society surveyed management techniques across the globe.
The twice-daily treatment may improve tolerability and compliance.
Researchers say identifying patients predisposed to the ocular surface disease can help guide treatment.
The study suggests a potential downstream effects of desiccation stress on corneal homeostasis.
Researchers say the study suggests the potential for a new generation of ocular surface therapies.
A study suggests measuring blinking during conversation and while viewing a video display might be valuable information to gauge functional impact of tear dysfunction.
Researchers detail the dry eye signs and symptoms in patients using aromatase inhibitor therapy.
Contact lens wearers with dry eye demonstrated a greater number of inflammatory markers, such as interleukins.
John Berdahl, MD, and Lawrence Woodward, MD, present an overview of the latest technologies available in eye care.
Signs, symptoms, and severity of dry eye were all elevated among patients who used topical hypotensive medications for glaucoma.